-
2
-
-
58149129750
-
Causes of preventable drug-related hospital admissions: A qualitative study
-
Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care 2008; 17(2): 109-116.
-
(2008)
Qual Saf Health Care
, vol.17
, Issue.2
, pp. 109-116
-
-
Howard, R.1
Avery, A.2
Bissell, P.3
-
3
-
-
0345600187
-
Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts
-
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716-2724.
-
(2003)
Arch Intern Med
, vol.163
, Issue.22
, pp. 2716-2724
-
-
Fick, D.M.1
Cooper, J.W.2
Wade, W.E.3
-
4
-
-
0035899838
-
Assessing care of vulnerable elders: ACOVE project overview
-
Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med 2001; 135(8 Pt 2): 642-646.
-
(2001)
Ann Intern Med
, vol.135
, Issue.8 PART 2
, pp. 642-646
-
-
Wenger, N.S.1
Shekelle, P.G.2
-
5
-
-
39049123608
-
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
-
Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46(2): 72-83.
-
(2008)
Int J Clin Pharmacol Ther
, vol.46
, Issue.2
, pp. 72-83
-
-
Gallagher, P.1
Ryan, C.2
Byrne, S.3
-
6
-
-
78249287514
-
Medication prescribing and monitoring errors in primary care: A report from the Practice Partner Research Network
-
Wessell AM, Litvin C, Jenkins RG, et al. Medication prescribing and monitoring errors in primary care: a report from the Practice Partner Research Network. Qual Saf Health Care 2010; 19(5): e21.
-
(2010)
Qual Saf Health Care
, vol.19
, Issue.5
-
-
Wessell, A.M.1
Litvin, C.2
Jenkins, R.G.3
-
7
-
-
70249102094
-
The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study
-
Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 2009; 27(3): 153-159.
-
(2009)
Scand J Prim Health Care
, vol.27
, Issue.3
, pp. 153-159
-
-
Rognstad, S.1
Brekke, M.2
Fetveit, A.3
-
8
-
-
50249083293
-
Inappropriate medication use and prescribing indicators in elderly Australians: Development of a prescribing indicators tool
-
Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 2008; 25(9): 777-793.
-
(2008)
Drugs Aging
, vol.25
, Issue.9
, pp. 777-793
-
-
Basger, B.J.1
Chen, T.F.2
Moles, R.J.3
-
9
-
-
33646352689
-
Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients
-
Raebel MA, Chester EE, Newsom EE, et al. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. Pharmacotherapy 2006; 26(5): 619-626.
-
(2006)
Pharmacotherapy
, vol.26
, Issue.5
, pp. 619-626
-
-
Raebel, M.A.1
Chester, E.E.2
Newsom, E.E.3
-
10
-
-
15044360335
-
Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
-
Zhan C, Correa-de-Araujo R, Bierman AS, et al. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. J Am Geriatr Soc 2005; 53(2): 262-267.
-
(2005)
J Am Geriatr Soc
, vol.53
, Issue.2
, pp. 262-267
-
-
Zhan, C.1
Correa-de-Araujo, R.2
Bierman, A.S.3
-
11
-
-
0031048342
-
Defining inappropriate practices in prescribing for elderly people: A national consensus panel
-
McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156(3): 385-391.
-
(1997)
CMAJ
, vol.156
, Issue.3
, pp. 385-391
-
-
McLeod, P.J.1
Huang, A.R.2
Tamblyn, R.M.3
Gayton, D.C.4
-
12
-
-
0032449144
-
Investigating relationships between a range of potential indicators of general practice prescribing: An observational study
-
Avery AJ, Heron T, Lloyd D, et al. Investigating relationships between a range of potential indicators of general practice prescribing: an observational study. J Clin Pharm Ther 1998; 23(6): 441-450.
-
(1998)
J Clin Pharm Ther
, vol.23
, Issue.6
, pp. 441-450
-
-
Avery, A.J.1
Heron, T.2
Lloyd, D.3
-
13
-
-
0034641523
-
Prescribing indicators for UK general practice: Delphi consultation study
-
Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000; 321: 425-428.
-
(2000)
BMJ
, vol.321
, pp. 425-428
-
-
Campbell, S.M.1
Cantrill, J.A.2
Roberts, D.3
-
14
-
-
2942750206
-
Indicators for preventable drug related morbidity: Application in primary care
-
Morris CJ, Rodgers S, Hammersley VS, et al. Indicators for preventable drug related morbidity: application in primary care. Qual Saf Health Care 2004; 13(3): 181-185.
-
(2004)
Qual Saf Health Care
, vol.13
, Issue.3
, pp. 181-185
-
-
Morris, C.J.1
Rodgers, S.2
Hammersley, V.S.3
-
15
-
-
80054061891
-
Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method
-
DOI: 10.3399/bjgp11X588501
-
Avery AJ, Dex GM, Mulvaney C, et al. Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method. Br J Gen Pract 2011; DOI: 10.3399/bjgp11X588501.
-
(2011)
Br J Gen Pract
-
-
Avery, A.J.1
Dex, G.M.2
Mulvaney, C.3
-
16
-
-
84859434544
-
A pharmacist-led information technology intervention for medication errors (PINCER): A multicentre, cluster randomised, controlled trial and cost-effectiveness analysis
-
Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012; 379: 1310-1319.
-
(2012)
Lancet
, vol.379
, pp. 1310-1319
-
-
Avery, A.J.1
Rodgers, S.2
Cantrill, J.A.3
-
17
-
-
84859001319
-
High risk prescribing in primary care patients particularly vulnerable to adverse drug events: Cross sectional population database analysis in Scottish general practice
-
Guthrie B, McCowan C, Davey P, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011; 342: d3514.
-
(2011)
BMJ
, vol.342
-
-
Guthrie, B.1
McCowan, C.2
Davey, P.3
-
18
-
-
18744414215
-
The application of prescribing indicators to a primary care prescription database in Ireland
-
Williams D, Bennett K, Feely J. The application of prescribing indicators to a primary care prescription database in Ireland. Eur J Clin Pharmacol 2005; 61(2): 127-133.
-
(2005)
Eur J Clin Pharmacol
, vol.61
, Issue.2
, pp. 127-133
-
-
Williams, D.1
Bennett, K.2
Feely, J.3
-
19
-
-
27944488779
-
Reliability of a modified medication appropriateness index in primary care
-
Bregnhøj L, Thirstrup S, Kristensen MB, Sonne J. Reliability of a modified medication appropriateness index in primary care. Eur J Clin Pharmacol 2005; 61(10): 769-773.
-
(2005)
Eur J Clin Pharmacol
, vol.61
, Issue.10
, pp. 769-773
-
-
Bregnhøj, L.1
Thirstrup, S.2
Kristensen, M.B.3
Sonne, J.4
-
20
-
-
33745033333
-
Applying preventable drug-related morbidity indicators to the electronic patient record in UK primary care: Methodological development
-
Hammersley VS, Morris CJ, Rodgers S, et al. Applying preventable drug-related morbidity indicators to the electronic patient record in UK primary care: methodological development. J Clin Pharm Ther 2006; 31(3): 223-229.
-
(2006)
J Clin Pharm Ther
, vol.31
, Issue.3
, pp. 223-229
-
-
Hammersley, V.S.1
Morris, C.J.2
Rodgers, S.3
-
22
-
-
25844453682
-
-
Joint Formulary Committee. 63rd ed. London: BMJ Group and RPS Publishing
-
Joint Formulary Committee. British national formulary. 63rd ed. London: BMJ Group and RPS Publishing, 2012.
-
(2012)
British National Formulary
-
-
-
23
-
-
70350664920
-
-
9th edn. London: Royal Pharmaceutical Society of Great Britain; Pharmaceutical Press
-
Baxter K, ed. Stockley's drug interactions. 9th edn. London: Royal Pharmaceutical Society of Great Britain; Pharmaceutical Press, 2010.
-
(2010)
Stockley's Drug Interactions
-
-
Baxter, K.1
-
25
-
-
0003423053
-
-
Santa Monica, CA: RAND, accessed 22 Jan 2014
-
RAND Health. RAND/UCLA appropriateness method. Santa Monica, CA: RAND, 2001. http://www.rand.org/health/surveys-tools/appropriateness.html (accessed 22 Jan 2014).
-
(2001)
RAND/UCLA Appropriateness Method
-
-
-
26
-
-
78049263531
-
-
NHS Institute for Innovation and Improvement. Coventry: NHS Institute for Innovation and Improvement
-
NHS Institute for Innovation and Improvement. The good indicators guide: understanding how to use and choose indicators. Coventry: NHS Institute for Innovation and Improvement, 2008.
-
(2008)
The Good Indicators Guide: Understanding How to Use and Choose Indicators
-
-
-
27
-
-
64749086705
-
Appropriateness criteria: A useful tool for the cardiologist
-
Shekelle PG. Appropriateness criteria: a useful tool for the cardiologist. Heart 2009; 95(7): 517-520.
-
(2009)
Heart
, vol.95
, Issue.7
, pp. 517-520
-
-
Shekelle, P.G.1
-
28
-
-
0036901660
-
Research methods used in developing and applying quality indicators in primary care
-
Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care 2002; 11(4): 358-364.
-
(2002)
Qual Saf Health Care
, vol.11
, Issue.4
, pp. 358-364
-
-
Campbell, S.M.1
Braspenning, J.2
Hutchinson, A.3
Marshall, M.4
-
29
-
-
84886941790
-
Developing consensus on hospital prescribing indicators of potential harms amenable to decision support
-
Thomas SK, McDowell SE, Hodson J, et al. Developing consensus on hospital prescribing indicators of potential harms amenable to decision support. Br J Clin Pharmacol 2013; 76(5): 797-809.
-
(2013)
Br J Clin Pharmacol
, vol.76
, Issue.5
, pp. 797-809
-
-
Thomas, S.K.1
McDowell, S.E.2
Hodson, J.3
-
30
-
-
84856591749
-
Quality and safety of medication use in primary care: Consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement
-
Dreischulte T, Grant AM, McCowan C, et al. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol 2012; 12: 5.
-
(2012)
BMC Clin Pharmacol
, vol.12
, pp. 5
-
-
Dreischulte, T.1
Grant, A.M.2
McCowan, C.3
-
31
-
-
84898753963
-
Prescribing long-acting beta2-agonist inhalers in asthma
-
DOI: 10.1002/psb.784
-
Spencer R, Serumaga B. Prescribing long-acting beta2-agonist inhalers in asthma. Prescriber 2011; 22(15-16): 26-28. DOI: 10.1002/psb.784.
-
(2011)
Prescriber
, vol.22
, Issue.15-16
, pp. 26-28
-
-
Spencer, R.1
Serumaga, B.2
-
32
-
-
84898718947
-
Concurrent macrolide and statin: A common interaction
-
DOI: 10.1002/psb.796
-
Spencer R, Serumaga B. Concurrent macrolide and statin: a common interaction. Prescriber 2011; 22(17): 49-50. DOI: 10.1002/psb.796.
-
(2011)
Prescriber
, vol.22
, Issue.17
, pp. 49-50
-
-
Spencer, R.1
Serumaga, B.2
-
33
-
-
84872260953
-
Prescribing antiemetics for patients with Parkinson's
-
DOI: 10.1002/psb.804
-
Spencer R, Serumaga B. Prescribing antiemetics for patients with Parkinson's. Prescriber 2011; 22(18): 48-49. DOI: 10.1002/psb.804.
-
(2011)
Prescriber
, vol.22
, Issue.18
, pp. 48-49
-
-
Spencer, R.1
Serumaga, B.2
-
34
-
-
84898758545
-
Co-prescription of a nitrate or nicorandil with a PDE-5 inhibitor
-
DOI: 10.1002/psb.816
-
Spencer R, Serumaga B. Co-prescription of a nitrate or nicorandil with a PDE-5 inhibitor. Prescriber 2011; 22(19): 71-72. DOI: 10.1002/psb.816.
-
(2011)
Prescriber
, vol.22
, Issue.19
, pp. 71-72
-
-
Spencer, R.1
Serumaga, B.2
-
35
-
-
84898734082
-
Digoxin doses over 125ìg daily in vulnerable patient groups
-
DOI: 10.1002/psb.841
-
Spencer R, Serumaga B. Digoxin doses over 125ìg daily in vulnerable patient groups. Prescriber 2011; 22(22): 34-35. DOI: 10.1002/psb.841.
-
(2011)
Prescriber
, vol.22
, Issue.22
, pp. 34-35
-
-
Spencer, R.1
Serumaga, B.2
-
36
-
-
84890933482
-
Beta-blockers in patients with asthma and COPD
-
DOI: 10.1002/psb.866
-
Spencer R, Serumaga B. Beta-blockers in patients with asthma and COPD. Prescriber 2012; 23(4): 14-16. DOI: 10.1002/psb.866.
-
(2012)
Prescriber
, vol.23
, Issue.4
, pp. 14-16
-
-
Spencer, R.1
Serumaga, B.2
|